← Back to Search

Community-based Psychological Services for Mental Health (RECOUP-NY Trial)

N/A
Recruiting
Led By Brandon Kohrt, MD, PhD
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
No functional impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks after baseline assessment
Awards & highlights

Summary

This trialstudies ways to improve mental health for minority & vulnerable groups during the pandemic, & the impact of mental health services on prevention behaviors, vaccinations & healthcare utilization.

Who is the study for?
This trial is for individuals in New York City who are experiencing depression, anxiety, or other psychological distress after SARS-CoV-2. Participants should have a certain score on a health questionnaire and be struggling with daily activities due to their mental state. People at acute suicide risk or without functional impairment cannot join.
What is being tested?
The study tests 'Problem Management Plus', a mental health service, against the usual services provided. It aims to see if this can improve behaviors related to preventing SARS-CoV-2 spread, vaccination uptake, and safe healthcare use among minority and vulnerable groups.
What are the potential side effects?
Since this trial involves psychological services rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any disabilities that affect my daily activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks after baseline assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks after baseline assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Psychological Outcome Profiles Questionnaire; Unabbreviated scale title "Psychological Outcome Profiles questionnaire"
Secondary study objectives
Coronavirus disease of 2019 experiences and attitudes tool; Unabbreviated scale title "Coronavirus disease of 2019 experiences and attitudes tool"
Generalized Anxiety Disorder 7; Unabbreviated scale title "Generalized Anxiety Disorder 7"
Patient Health Questionnaire 9; Unabbreviated scale title "Patient Health Questionnaire 9"
+2 more
Other study objectives
Intolerance of Uncertainty Scale-Short Form; Unabbreviated title "Intolerance of Uncertainty Scale-Short Form"
Reducing Tension Checklist, Unabbreviated title "Reducing Tension Checklist"

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Problem Management PlusExperimental Treatment1 Intervention
Persons screening positive for depression will be offered Problem Management Plus delivered by community based organization staff.
Group II: Services as usualActive Control1 Intervention
Persons screening positive for depression will be referred from community-based organizations. The referrals will be made to mental health specialists who will provide care based on their standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Problem Management Plus
2018
N/A
~120

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor
250 Previous Clinical Trials
457,810 Total Patients Enrolled
13 Trials studying Depression
10,606 Patients Enrolled for Depression
The New SchoolOTHER
4 Previous Clinical Trials
381 Total Patients Enrolled
1 Trials studying Depression
45 Patients Enrolled for Depression
Duke UniversityOTHER
2,424 Previous Clinical Trials
3,065,084 Total Patients Enrolled
75 Trials studying Depression
33,255 Patients Enrolled for Depression

Media Library

Problem Management Plus Clinical Trial Eligibility Overview. Trial Name: NCT04913766 — N/A
Depression Research Study Groups: Services as usual, Problem Management Plus
Depression Clinical Trial 2023: Problem Management Plus Highlights & Side Effects. Trial Name: NCT04913766 — N/A
Problem Management Plus 2023 Treatment Timeline for Medical Study. Trial Name: NCT04913766 — N/A
~405 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top